The Nordic region has long produced world-leading science and innovation and Nasdaq Nordic is one of the leading hubs for biotech companies in Europe, strengthened further by a hugely active IPO market over the last two years. However, growth and venture funding is lacking compared with other hubs and listed Nordic companies face a number of specific challenges in their ongoing funding, growth, development and internationalization.
With our relentless focus on quality peer-to-peer discussion, high-level networking and partnering, unique formats and a vetted, high-calibre audience, we will bring together the people that matter to the future of life sciences in the Nordic region to address these challenges and work towards actionable outcomes to help it flourish.
